Patients after curative intent resection of cholangiocarcinoma research hub

Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)

This study looks at extra medicine (chemotherapy) after surgery for certain bile duct or gallbladder cancers. It compares a standard treatment to a new combination, hoping to stop the cancer from coming back and help people live longer and better.